Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/27/1996WO1996041869A1 Cis-9,10-octadecenoamidase
12/27/1996WO1996041807A1 Rapamycin derivatives
12/27/1996WO1996041796A1 Bicyclolactam compounds, use of the same and intermediate in the production of the same
12/27/1996WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists
12/27/1996WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
12/27/1996WO1996041643A1 Antiviral method and antiviral agent
12/27/1996WO1996041639A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
12/27/1996WO1996041635A1 Pharmaceutical compositions containing a diclofenac salt and thiocolchicoside
12/27/1996WO1996041634A2 Use of a non-nucleoside reverse transcriptase inhibitor in association with nucleoside inhibitors for the treatment of hiv infection
12/27/1996WO1996041632A1 Starch microsphere anti migraine composition
12/27/1996WO1996041631A1 Methods of treating cold and allergic rhinitis
12/27/1996WO1996041630A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system
12/27/1996WO1996041629A1 Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system
12/27/1996WO1996041628A1 Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast
12/27/1996WO1996041627A2 Iron compounds, compositions, methods of making the same and uses thereof
12/27/1996WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/27/1996WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
12/27/1996WO1996041624A1 TNF-α CONVERTING ENZYME
12/27/1996WO1996041619A1 Controlled release of drugs delivered by sublingual or buccal administration
12/27/1996WO1996041618A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/27/1996WO1996041616A1 Formulations and methods for providing prolonged local anesthesia
12/27/1996WO1996041609A2 Methods and compositions for stimulating neurite growth
12/27/1996WO1996041536A1 Agent for combating parasites in farmed fish
12/27/1996WO1996041534A1 Use of oxazolines for combatting ectoparasites
12/27/1996WO1996037226A3 Combinations for the treatment of parkinsonism containing selective nmda antagonists
12/27/1996WO1996030395A3 Cysteine protease inhibitor
12/27/1996WO1996025956A3 Individual medicament dosing conjugate
12/27/1996WO1996021731A3 Stabilized external guide sequences
12/27/1996EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination
12/27/1996EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase
12/27/1996EP0749982A1 Antioxidant grafted polysaccharides and their uses
12/27/1996EP0749977A2 Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
12/27/1996EP0749971A1 Thiopyran derivatives
12/27/1996EP0749970A1 Benzisothiazolyl-substituted aminomethylchroman derivatives
12/27/1996EP0749969A2 d4T polymorphic form I process
12/27/1996EP0749967A1 Substituted benzothiazine derivative
12/27/1996EP0749964A1 N-Heterocyclyl biphenyl sulfonamides
12/27/1996EP0749960A1 Process for the synthesis of cationic surfactants obtained from the condensation of fatty acids with esterified dibasic aminoacids, and their application as antimicrobial agents
12/27/1996EP0749752A1 Use of specific RXR receptor ligands
12/27/1996EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes
12/27/1996EP0749697A1 Coated food
12/27/1996EP0749496A1 Human dna mismatch repair proteins
12/27/1996EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION
12/27/1996EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
12/27/1996EP0749476A1 Mediators of chronic allograft rejection
12/27/1996EP0749452A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
12/27/1996EP0749438A1 Novel silyl compounds and their use
12/27/1996EP0749437A1 Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses
12/27/1996EP0749434A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/27/1996EP0749432A1 9-deoxotaxane compounds
12/27/1996EP0749430A1 Thiazolidinedione derivatives as anti-hyperglycemic agents
12/27/1996EP0749429A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
12/27/1996EP0749428A1 Isoxazoline compounds as inhibitors of tnf release
12/27/1996EP0749425A1 New piperazine derivatives and methods for the preparation thereof and compositions containing the same
12/27/1996EP0749424A1 Naphthalene derivatives as prostaglandin i2 agonists
12/27/1996EP0749423A1 Piperidines and pyrrolidines
12/27/1996EP0749422A1 Indole derivatives as cck receptor antagonists
12/27/1996EP0749421A1 Sulphonamide derivatives as aspartyl protease inhibitors
12/27/1996EP0749418A1 L-n6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
12/27/1996EP0749417A1 Cyano compounds and preparations thereof
12/27/1996EP0749415A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
12/27/1996EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS
12/27/1996EP0749316A1 Antithrombotic agents
12/27/1996EP0749314A1 Method for treating and inhibiting gastric and duodenal ulcers
12/27/1996EP0749313A1 Method for treating 5ht 2b receptor related conditions
12/27/1996EP0749311A1 Pharmaceutical composition of indene derivatives for regulating apoptosis
12/27/1996EP0749310A1 New use of quinoline-3-carboxamide compounds
12/27/1996EP0749309A1 Treatment of obsessive-compulsive disorders with 5-ht 2? antagonists
12/27/1996EP0749308A1 Film coated tablet of paracetamol and domperidone
12/27/1996EP0749307A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
12/27/1996EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
12/27/1996EP0749305A1 Process for making avermectin/zein compositions
12/27/1996EP0749304A1 Slow-release tablet containing diclofenac-na
12/27/1996EP0749303A1 Method of treating disorders of the eye
12/27/1996EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
12/27/1996EP0680326B1 Pharmaceutical composition for treating nicotine dependence
12/27/1996EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical
12/27/1996EP0660720A4 Skin-conditioning composition, its application and manufacture.
12/27/1996EP0610265B1 Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
12/27/1996EP0580641B1 New thalidomide derivatives, method of manufacture and use thereof in medicaments
12/27/1996EP0572635B1 Compounds having a guanidine structure and pharmaceutical compositions containing same
12/27/1996EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them
12/27/1996EP0500835B1 A novel quinolone carboxylic acid derivative
12/27/1996CA2349017A1 Formulations and methods for providing prolonged local anesthesia
12/27/1996CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
12/27/1996CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
12/27/1996CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
12/27/1996CA2224156A1 Dry powder formulations of polynucleotide complexes
12/27/1996CA2224146A1 Improved pharmaceutical compositions for gene therapy
12/27/1996CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists
12/27/1996CA2223568A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
12/27/1996CA2223147A1 Use of oxazolines for combatting ectoparasites
12/27/1996CA2222430A1 Methods and compositions for stimulating neurite growth
12/27/1996CA2222226A1 Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system
12/27/1996CA2222225A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system
12/27/1996CA2179314A1 Esters and amides of 9(z)-retinoic acid
12/25/1996CN2243299Y Scopolamine dressing for controllable release on belly
12/25/1996CN1138865A Peptides and methods against psoriasis
12/25/1996CN1138862A Watersoluble azole antifungals
12/25/1996CN1138861A 2-heteroaryl-5,11-dihydro-6H-dipyrido|3,2-b:2',3'-3¨|1,4¨diazepines and their use in the prevention or treatment of HIV infection
1 ... 6843 6844 6845 6846 6847 6848 6849 6850 6851 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 ... 7860